THE ECONOMIC BURDEN OF SEPSIS
The CDC defines Sepsis as the body’s radical and toxic response to an infection, and it is a life-threatening emergency that requires rapid diagnosis and treatment. Without rapid diagnosis and treatment sepsis can quickly lead to tissue damage, organ failure, and death.
Sepsis is a medical emergency caused by the bodies response to an infection and is the result of inflammation in the body. This inflammation and blood clotting reduces blood flow to limbs and the bodies vital organs and can lead to organ failure and even death.
Sepsis Resources
Click on the following articles on Sepsis to learn more.
What is Sepsis?
The Sepsis Innovation Challenge
The Human Cost of Sepsis
The Economic Cost of Sepsis
SEPSIS – COMPLEX & COSTLY BURDEN
- $62 billion estimated annual cost of treatment & care
- $3.5 billion estimated annual cost of readmissions
- $34 million annual margin loss to hospitals > 500 beds
- $10 million annual margin loss to hospitals < 200 beds
- #1 cause of deaths in hospitals
- #1 cause of hospital readmissions
- #1 cost to hospitals
Readmissions can be a very costly part of sepsis management and directly impact a hospital’s bottom line. If patients treated for a disease return to the hospital after discharge this not only results in additional treatment costs, but also puts the hospital at risk of reduced payments and even penalties under the CMS Hospital Readmission Reduction Program.
One of the largest -ever studies of Medicare sepsis data was conducted by researchers from the U.S. Department of Health and Human Services. The journal of Critical Care Medicine has published the research in three articles and numerous other studies have found significant implications for patient care, industry, non-government organizations, and government agencies. The results of these studies can be found by clicking the links below.
-
Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012–2018*
-
Sepsis Among Medicare Beneficiaries: 2. The Trajectories of Sepsis, 2012–2018*
-
Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012–2018*
-
Sepsis poses a cost-containment challenge in the face of the COVID-19 pandemic
PERSOWN is working with data analytics leader SAS to bring affordable, lifesaving, early detection Sepsis technology to clinicians, researchers, and governments to reduce sepsis deaths globally, improve patients’ lives, and strengthen the financial position of healthcare networks
WE’RE SEEKING INTEGRATION PARTNERS
We seek collaborative hospitals from around the world to launch the CAPS platform for clinical researchers and treatment protocol analytics.
